Patent · US Expired

Detection of melanoma or breast metastasis with a multiple marker assay

US6057105A · kind A · utility

110Cited by

0References

85Claims

0Family size

Assignee

NGI/Cancer Tech Company, LLC · US

Inventors

Dave S.B. Hoon · Los Angeles, US
Andrew Conrad · Los Angeles, US
Peter Schmid · Rain, DE

Key dates

Filing date	Dec 9, 1997
Grant date	May 2, 2000
Priority date	—
Expiry date	Dec 9, 2017

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods for detecting metastasis of melanoma and breast cancer cells, detecting subclinical metastasis, and monitoring treatment are disclosed. Kits for use in such methods also are disclosed. The methods provide for the detection of nucleic acids corresponding to multiple melanoma or breast cancer specific markers using template dependent amplification processes. Methods using multiple markers provide increased sensitivity over existing methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.